Nutriband (NASDAQ: NTRB) , a developer of transdermal Pharmaceutical products, has authorized a share repurchase program to buy back up to $1 million of its common stock. According to the announcement ...
The Concurrent Repurchase is being executed separately from the Companyâs existing $500 million sharerepurchase program authorized on May 24, 2024, which will be unaffected by this transaction.